Hepatitis B virus-associated glomerulonephritis

Hepatitis Monthly

Volumn 9, Issue 2, 2009, Pages 137-145

  Khedmat, Hossein ^a   Taheri, Saeed ^a,b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dr Taheri Medical Research Group   (Iran)

Author keywords

Glomerular Disease; Hepatitis B Virus; Nephropathy

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

CLINICAL FEATURE; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY DISEASE; NEPHROTIC SYNDROME; PATHOGENESIS; PREVALENCE; PROGNOSIS; PROTEINURIA; REVIEW; SEXUAL TRANSMISSION; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS TRANSMISSION;

EID: 70349300425     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Levy M, Kleinknecht C. Membranous glomerulonephritis and hepatitis B virus infection. Nephron. 1980;26(6):259-65.
2. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol. 1997;92(1):3-17.
3. Koff R. Immunologically mediated extrahepatic manifestations of viral hepatitis. In: Krawitt EL, Wiesner RH, editors. Autoimmune Liver Diseases. New York: Raven press; 1991. p. 233-45.
4. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology. 1995;108(1):157-64.
5. Shusterman N, London WT. Hepatitis B and immunecomplex disease. N Engl J Med. 1984;310(1):43-6.
6. Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 1971;2(7718):234-7.
7. Nagy J, Bajtai G, Brasch H, et al. HBsaG in renal disease. Lancet. 1978;2(8084):315-6.
8. Bajtai G, Ambrus M, Paal M, Nagy J, Deak G. Letter: Hepatitis-B antigenaemia associated with progressive cirrhosis and membranous glomerulonephritis. Lancet. 1975;1(7898):102-3.
9. Safadi R, Almog Y, Dranitzki-Elhalel M, Rosenmann E, Tur-Kaspa R. Glomerulonephritis associated with acute hepatitis B. Am J Gastroenterol. 1996;91(1):138-9.
10. Amarapurkar D, Kirpalani A, Amarapurkar A. Role of Hepatitis B in Glomerulonephritis. Available from: http://bhj.org/journal/2001_4301_jan/ original_128.htm.
11. Knieser MR, Jenis EH, Lowenthal DT, Bancroft WH, Burns W, Shalhoub R. Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol. 1974;97(4):193-200.
12. Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet. 1974;2(7879):477-82.
13. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M. Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med. 1979; 300(15):814-9.
14. Ito H, Hattori S, Matusda I, et al. Hepatitis B e antigen-mediated membranous glomerulonephritis. Correlation of ultrastructural changes with HBeAg in the serum and glomeruli. Lab Invest. 1981; 44(3):214-20.
15. Takeda S, Kida H, Katagiri M, Yokoyama H, Abe T, Hattori N. Characteristics of glomerular lesions in hepatitis B virus infection. Am J Kidney Dis. 1988;11(1):57-62.
16. Ishihara T, Akamatsu A, Takahashi M, et al. Ultrastructure of kidney from three patients with HBeAg-associated nephropathy with special reference to virus-like particles in the glomerular tufts. Acta Pathol Jpn. 1988;38(3):339-50.
17. Furuse A, Hattori S, Terashima T, Karashima S, Matsuda I. Circulating immune complex in glomerulonephropathy associated with hepatitis B virus infection. Nephron. 1982;31(3):212-8.
18. Hirose H, Udo K, Kojima M, et al. Deposition of hepatitis B e antigen in membranous glomerulonephritis: identification by F(ab′)2 fragments of monoclonal antibody. Kidney Int. 1984; 26(3):338-41.
19. Zhang Y, Fang L, Ma X. [Hepatitis B virus infection and pathogenesis of glomerulonephritis]. Zhonghua Bing Li Xue Za Zhi. 1995; 24(6):341-4.
20. Zhang Y, Ma X, Fang L, Lin S, Wu Z, Gu J. The existence and significance of hepatitis B virus DNA in glomerulonephritis. Nephrology. 1996;2(2):119-25.
21. Zhang YE, Guo MY, Ying YY. [Further study on the immunopathology of hepatitis B virus associated glomerulonephritis]. Zhonghua Nei Ke Za Zhi. 1990;29(9):526-9, 74.
22. Zhang YE, Guo MY, Yin JF, et al. [Immunopathological study of hepatitis B virus immune complex glomerulonephritis]. Zhonghua Shenzangbing Zazhi. 1986;2:127-30.
23. Thyagarajan SP, Thirunalasundari T, Subramanian S, et al. Serum and tissue positivity for hepatitis B virus markers in histopathologically proven glomerulonephropathies. J Med Microbiol. 1989;29(4):243-9.
24. Zhou WZ, Zhang WL, Geng L. [Glomerulonephropathy associated with hepatitis B virus (HBV) infection]. Zhonghua Nei Ke Za Zhi. 1990;29(9):530-3, 74.
25. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 1990;37(2):663-76.
26. Lin CY. Hepatitis B virus deoxyribonucleic acid in kidney cells probably leading to viral pathogenesis among hepatitis B virus associated membranous nephropathy patients. Nephron. 1993;63(1):58-64.
27. Ma XL, Zhang XR, Du WD, Zhu TF, Zhao ZH, Zhang YE. [Detection of HBV DNA and HBAg in renal tissue of IgA nephropathy by using double staining technology]. Shanghai Yike Daxue Xuebao. 1997;24:293-4.
28. Yan HP, Lang ZW, Huang DZ. [Preparation of digoxigenin labelled probe and detection of HBV DNA in liver and extrahepatic tissue with in situ hybridization]. Zhonghua Nei Ke Za Zhi. 1994;33(3):168-71.
29. Fang LJ, Guo YQ ZYE, Gu JR, Jiang HQ. [The study on HBV DNA state in renal tissue of children HBV associated glomerulonephritis]. Zhonghua Shenzangbing Zazhi. 1992;8:65-7.
30. Fang LJ, Sheng FY, Guo YQ, et al. [Hepatitis B virus associated nephritis in adults and children]. Zhonghua Chuanranbingxue Zazhi. 1996;14:92-5.
31. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med. 1987;63(240):323-33.
32. Lai KN, Lai FM, Tam JS, Vallance-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol. 1988;29(5):229-34.
33. Lai KN, Ho RT, Tam JS, Lai FM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis. Kidney Int. 1996;50(6):1965-77.
34. He XY, Fang LJ, Zhang YE, Sheng FY, Zhang XR, Guo MY. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol. 1998;12(2):117-20.
35. Magil A. IgA nephropathy and membranous nephropathy associated with hepatitis B surface antigenemia. Hum Pathol. 1988; 19(5):615.
36. Wang NS, Wu ZL, Zhang YE, Liao LT, Guo MY. [Is there relationship between IgA nephropathy (IgAN) and hepatitis B virus (HBV)]. Zhonghua Shenzangbing Zazhi. 1996;12:276-8.
37. Levy M, Gagnadoux MF. Membranous nephropathy following perinatal transmission of hepatitis B virus infection - long-term follow-up study. Pediatr Nephrol. 1996;10(1):76-8.
38. Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H. Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child. 1983;58(7):488-96.
39. Venkataseshan VS, Lieberman K, Kim DU, et al. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine (Baltimore). 1990;69(4):200-16.
40. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int. 1995; 47(1):225-30.
41. Lai KN, Li PK, Lui SF, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med. 1991; 324(21):1457-63.
42. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology. 1994;198(2):489-503.
43. Wei Y, Fourel G, Renard C-A, M-A. B, Tiollais P. Hepatitis B viruses and hepatocellular carcinoma. In: Viral hepatitis A to F: an update. Chicago: American Association for the Study of Liver Diseases,. 1994.
44. Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet. 1993;342(8883):1335-40.
45. Mutchnick MG. Acute and chronic hepatitis B. In: Feldman M, Maddrey WC, editors. The liver. Philadelphia: Current Medicine; 1996. p. 1-4, 24.
46. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24):1733-45.
47. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4):403-6.
48. Lai CL. Chronic hepatitis B in Hong Kong: immunization strategies for the control of hepatitis B virus infection. In: Zuckerman H, editor. Hepatitis B in the Asian-Pacific region: screening, diagnosis and control. London: Royal College of Physician; 1997. p. 79-87.
49. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang. 1979;37(3):182-6.
50. Kowdley KV. The cost of managing chronic hepatitis B infection: a global perspective. J Clin Gastroenterol. 2004;38(10 Suppl 3):S132-3.
51. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18 Suppl 1:S20-2.
52. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
53. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006; 28:112-25.
54. Lin HH, Kao JH, Chang TC, Hsu HY, Chen DS. Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol. 2003;69(4):466-70.
55. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38 Suppl 2:S39-42.
56. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158-68.
57. Seeff LB, Beebe GW, Hoofnagle JH, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med. 1987;316(16):965-70.
58. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990; 150(5):1051-4.
59. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007; 45(2):507-39.
60. Bond WW, Petersen NJ, Favero MS. Viral hepatitis B: aspects of environmental control. Health Lab Sci. 1977;14(4):235-52.
61. Mast EE, Mahoney F, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. Philadelphia, PA: W B Saunders Company; 2004. p. 299-337.
62. Vehaskari VM, Robson AM. Proteinuria. In: Eldelmann CMJ, Bernstein J, Meadow SR, Spitzer A, Travis LB, editors. Pediatric Kidney Diseases. Boston: Little Brown; 1992. p. 531-51.
63. Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int. 1980;17(1):1-13.
64. Couser WG, Abrass CK. Pathogenesis of membranous nephropathy. Annu Rev Med. 1988;39:517-30.
65. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995;332(16):1065-9.
66. Germuth FG, Jr., Rodriguez E, Lorelle CA, Trump EI, Milano LL, Wise O. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits. Lab Invest. 1979;41(4):366-71.
67. Hsu HC, Lin GH, Chang MH, Chen CH. Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol. 1983;20(3):121-9.
68. Takekoshi Y, Tanaka M, Shida N, Satake Y, Saheki Y, Matsumoto S. Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet. 1978; 2(8099):1065-8.
69. Lin CY, Lin CC, Chang GJ, King CC. Defect of cell-mediated immune response against hepatitis B virus: an indication for pathogenesis of hepatitis-B-virus-associated membranous nephropathy. Nephron. 1997;76(2):176-85.
70. Zhou SD, Zhang YE, Guo MY, et al. The study of the significance of the appearance of HbcAg in glomerulonephritis. Chin J Nephrol. 1995;11:101-6.
71. Bhimma R, Coovadia M, Hammond MG, Kramvis A, Adhikari M, Kew MC. HLA associations with HBV carriage and proteinuria. Pediatr Nephrol. 2002;17(9):724-9.
72. Vaughan RW, Zurowska A, Moszkowska G, Kondeatis E, Clark AG. HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy. Tissue Antigens. 1998;52(2):130-4.
73. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron. 1990; 54(1):12-7.
74. Guerra IL, Abraham AA, Kimmel PL, Sabnis SG, Antonovych TT. Nephrotic syndrome associated with chronic persistent hepatitis B in an HIV antibody positive patient. Am J Kidney Dis. 1987; 10(5):385-8.
75. Cogan MG, Graber ML, Connor DG. Chronic active hepatitis and membraneous glomerulonephritis. Am J Gastroenterol. 1977;68(4):386-91.
76. Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V. Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatr. 1979;95(6):946-52.
77. Kohler PF, Cronin RE, Hammond WS, Olin D, Carr RI. Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med. 1974;81(4):448-51.
78. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol. 1994; 8(1):11-4.
79. Cadrobbi P, Bortolotti F, Zacchello G, Rinaldi R, Armigliato M, Realdi G. Hepatitis B virus replication in acute glomerulonephritis with chronic active hepatitis. Arch Dis Child. 1985;60(6):583-5.
80. Hoofnagle JH, Davis GL, Pappas SC, et al. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1986; 104(1):12-7.
81. Lai FM, Tam JS, Li PK, Lai KN. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch A Pathol Anat Histopathol. 1989; 414(3):279-84.
82. Al-Wakeel J, Mitwalli A, Tarif N, Al-Mohaya S, Malik G, Khalil M. Role of interferon-alpha in the treatment of primary glomerulonephritis. Am J Kidney Dis. 1999;33(6):1142-6.
83. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med. 1993;119(4):312-23.
84. Phillips TM. Interferon-alpha induces renal dysfunction and injury. Curr Opin Nephrol Hypertens. 1996;5(4):380-3.
85. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology. 1995; 109(2):540-6.
86. Abbas NA, Pitt MA, Green AT, Solomon LR. Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon. Nephrol Dial Transplant. 1999;14(5):1272-5.
87. Haria M, Benfield P. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis. Drugs. 1995;50(5):873-96.
88. Belardelli F, Gresser I. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today. 1996;17(8):369-72.
89. Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med. 1990;323(5):295-301.
90. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855-9.
91. Kew MC. Protective efficacy of hepatitis B vaccination. Lancet. 1995;345(8957):1065-6.
92. Hsu HM, Chen DS, Chuang CH, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA. 1988;260(15):2231-5.
93. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol. 1991; 34(2):96-9.
94. Whittle HC, Maine N, Pilkington J, et al. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet. 1995;345(8957):1089-92.
95. Line XM, Xu ZY, Ouyang PY, et al. Eight year survey for hepatitis B vaccine efficacy to newborns after universal immunisation. Chin J Exp Virol. 1995;9:55-8.
96. Li R, Yang J, Wang S. The effect of hepatitis B vaccination on epidemiology of hepatitis virus. Chin J Vaccine Immun. 1996; 2:56-60.
97. Zuckerman AJ. Prevention of primary liver cancer by immunization. N Engl J Med. 1997;336(26):1906-7.
98. Safary A, Beck J. Vaccination against hepatitis B: current challenges for Asian countries and future directions. J Gastroenterol Hepatol. 2000;15(4):396-401.
99. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2(8256):1129-33.
100. Wu WS, Shao ZP. A review of hepatitis B immunisation. Chin J Vaccine Immun. 1996;2:61-6.
101. Lee CL, Ko YC. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics. 1997;99(3):351-3.
102. Zhao S, Xu Z, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. Int J Epidemiol. 2000;29(4):744-52.
103. The People of South Africa, Population census 1996. Statistics South Africa; 1998. pp 4-22.
104. Lai KN. Hepatitis B virusc associated glomerulonephritis in adults. Nephrology. 1996;2(Suppl. 1):S72-S9.
105. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24(2):198-211.
106. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Provisional recommendations for hepatitis B vaccination of adults. Atlanta, GA: Centers for Disease Control and Prevention, 2005. (http://www.cdc.gov/nip/recs/provisional_recs/ hepB_adult.pdf).